Other tech
Sanofi’s mega US$1.6 billion Vicebio buyout once again shows the value of Aussie uni IP
Sanofi’s billion‑dollar buyout of Vicebio hands The University of Queensland its biggest commercial victory yet, putting the Molecular Clamp vaccine platform back in play after its COVID‑era false start and signalling fresh confidence in Aussie deep‑tech.
